$1.03
0.010.98%
Pre-Market: 5:41 PM EDT
15 minutes delayed
Comments
Loading...
Cyclacel Pharmaceuticals (NASDAQ:CYCC) Stock, Earnings Estimates, EPS, And Revenue
Cyclacel Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 14
EPS
$-0.720
Quarterly Revenue
$4K
Annual Revenue
(as of Jun 30)
(as of Jun 30)
$80K
Analyze the earnings history of Cyclacel Pharmaceuticals using advanced sorting and filters.
Data brought to you by Benzinga APIs
Cyclacel Pharmaceuticals (CYCC) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Jun 2024 | 2024-08-14 | $-0.72 | $-1.43 | 49.6 % |
| Mar 2024 | 2024-05-14 | $-2.27 | $-4.74 | 52.1 % |
| Dec 2023 | 2024-03-19 | $-6.23 | $-5.89 | -5.77 % |
| Sep 2023 | 2023-11-13 | $-7.35 | $-5.40 | -36.1 % |
Cyclacel Pharmaceuticals (CYCC) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Jun 2024 | 2024-08-14 | $4.00K | $30.00K | -86.7 % |
FAQ
When is Cyclacel Pharmaceuticals (NASDAQ:CYCC) reporting earnings?
Cyclacel Pharmaceuticals (CYCC) is scheduled to report earnings on November 11, 2024. The last reported earnings were for reported on August 14, 2024 for Q2.
What were the latest earnings per share (EPS) for Cyclacel Pharmaceuticals (NASDAQ:CYCC)?
The Actual EPS was $-0.72, which beat the estimate of $-1.43.
What were Cyclacel Pharmaceuticals’s (NASDAQ:CYCC) revenues?
The Actual Revenue was $4K, which missed the estimate of $30K.
Browse earnings estimates, EPS, and revenue on all stocks.